Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline...
11 KB (1,108 words) - 07:19, 1 September 2024
Saxenda for obesity, manufactured by Novo Nordisk), approved in 2010 albiglutide (Tanzeum, manufactured by GSK), approved in 2014 dulaglutide (Trulicity...
38 KB (3,935 words) - 21:33, 20 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
66 KB (5,428 words) - 08:55, 26 September 2024
receptor Glucagon-like peptide-2 Type 2 diabetes GLP-1 receptor agonists : albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide and semaglutide...
26 KB (3,386 words) - 20:05, 10 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
3 KB (184 words) - 13:53, 14 June 2024
rosuvastatin A10BJ01 Exenatide A10BJ02 Liraglutide A10BJ03 Lixisenatide A10BJ04 Albiglutide A10BJ05 Dulaglutide A10BJ06 Semaglutide A10BJ07 Beinaglutide A10BK01...
6 KB (508 words) - 06:49, 20 December 2023
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
44 KB (3,493 words) - 05:47, 15 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
41 KB (3,673 words) - 18:02, 22 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
16 KB (1,798 words) - 07:40, 1 February 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
151 KB (14,429 words) - 05:01, 15 September 2024
endogenous in humans oxyntomodulin exendin-4, exenatide lixisenatide albiglutide beinaglutide dulaglutide efpeglenatide langlenatide liraglutide PEG-...
33 KB (4,074 words) - 15:18, 18 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
11 KB (607 words) - 05:27, 10 June 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
4 KB (328 words) - 05:24, 6 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
22 KB (1,717 words) - 04:47, 27 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
16 KB (1,542 words) - 20:53, 21 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
24 KB (1,877 words) - 21:09, 21 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
53 KB (4,960 words) - 03:28, 26 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
8 KB (507 words) - 03:48, 24 June 2024
(Ozempic) (oral version is Rybelsus) Dulaglutide (Trulicity) - once weekly Albiglutide (Tanzeum) - once weekly These agents may also cause a decrease in gastric...
50 KB (5,222 words) - 18:06, 23 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
28 KB (2,659 words) - 21:25, 27 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
24 KB (2,331 words) - 05:51, 4 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
11 KB (760 words) - 13:42, 7 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
4 KB (275 words) - 18:01, 26 April 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
22 KB (2,076 words) - 12:57, 19 August 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
108 KB (11,440 words) - 15:04, 26 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
9 KB (284 words) - 09:11, 17 June 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
11 KB (905 words) - 23:37, 11 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
29 KB (2,960 words) - 20:56, 4 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
33 KB (2,855 words) - 21:09, 12 September 2024
K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
18 KB (1,514 words) - 15:51, 7 June 2024